New Issue | Current Pharmaceutical Analysis; Volume 16 Issue 3

Untitled-2

Current Pharmaceutical Analysis

Volume 16, Issue 3

AIMS & SCOPE

Current Pharmaceutical Analysis publishes full-length/mini reviews and original research articles on all the most recent advances in pharmaceutical and biomedical analysis. All aspects of the field are represented including drug analysis, analytical methodology and instrumentation. The journal is essential to all involved in pharmaceutical, biochemical and clinical analysis.

 

Articles from the Journal 

 

For more details on the articles, please visit HERE 

 

 

 

 

 

 

 

Advertise your event with Bentham Science

GET ADDITIONAL REGISTRATIONS TO YOUR EVENT

AND A BOOST TO YOUR ONLINE PRESENCE!

 

ADVERTISE-WITH-US.jpg

 

Representing Bentham Science, an established publisher of Scientific Journals and eBooks, we are pleased to offer our services for promoting your upcoming events, through our online and print journals, eBooks, websites and other digital platforms.

We have recently enhanced our advertising package which will help you generate a specific type of user action, such as registering to the event and will boost your online presence.

Bentham Science, an established STM publisher of over 100 scholarly journals and more than 800 books. Our publications cover 20 broad disciplines with a major focus on pharmaceutical and healthcare research. Our journals are indexed in all major indexing agencies including PubMed, Scopus, Web of Science, Clarivate Analytics etc. You can learn more about our high impact journals here.

To promote your event, we are offering online advertising services on our website and online (email campaigns and social media campaigns) channels for various scientific conferences. Our online platforms would be a good match for your conference, and will allow you to reach your target audience. More information is available on our 2019 Media Pack.

OUR ADVERTISING OFFERS

Email campaign to subscribers & contributors in the relevant field, you can custom select the audience as per your event 

*We have a list of 17,000 Editorial Board Members, 200,000 Bentham Science Contributors and 15,000 other subscribers

Our targeting criteria include:

  • Areas of Work (Oncology, Clinical Research, Pharmacology, Neuroscience, Molecular Biology, etc.)
  • Geography (USA, Europe, Asia, ME/Africa and RoW)
  • Job Titles
  • Institution Type (Academic / Commercial)

CPC Banner advertisements (First 10 clicks for FREE)

  • Banner advertisement on scholarly article pages of a relevant journal for a month (above 50 impressions per day for each banner).
  • Banner advertising on Table of Content alert to our Editorial Board Members, Subscribers and Contributors.
  • Banner advertisement on the home page of a relevant journal for a month.
  • Banner advertisement on the home page of a relevant eBook to your preference for a month.
  • Company logo on Media Partner’s section.
  • Banner advertisement under the partnering events section on Bentham Science website (Complimentary with the Package).

Social Media Promotion/Campaign (Twitter, Facebook, LinkedIn, WordPress)

In addition, we will provide you a detailed report regarding the performance of the ads, including the stats for the following:

✔Impressions

✔Clicks and CTR

✔Conversions (where possible)

You can also avail Print Advertising and Customized Email Promotion Packages with nominal costs that best suit your requirements. Visit us at: http://bit.ly/2snuJiQ

For details about the Packages and costs, please contact at hermain@benthamscience.net or faizan@benthamscience.net so that we may discuss the terms of our promotional partnership accordingly and work towards long term cooperation. If interested, we can arrange for a conference call to discuss this opportunity further.

Advertise your event with Bentham Science

BOOST YOUR ONLINE PRESENCE AND GET ADDITIONAL REGISTRATIONS TO YOUR EVENT!

ADVERTISE-WITH-US.jpg

 

We have recently enhanced our advertising package which will help you generate a specific type of user action, such as registering to the event and will boost your online presence.

Bentham Science is an established STM publisher of over 100 scholarly journals and more than 800 books. Our publications cover 20 broad disciplines with a major focus on pharmaceutical and healthcare research. Our journals are indexed in all major indexing agencies including PubMed, Scopus, Web of Science, Clarivate Analytics etc. You can learn more about our high impact journals here

To promote your event, we are offering online advertising services on our website and online (email campaigns and social media campaigns) channels for various scientific conferences. Our online platforms would be a good match for your conference, and will allow you to reach your target audience. More information is available on our 2019 Media Pack.

 

OUR ADVERTISING OFFERS

Email campaign to subscribers & contributors in the relevant field, you can custom select the audience as per your event 

*We have a list of 17,000 Editorial Board Members, 200,000 Bentham Science Contributors and 15,000 other subscribers

Our targeting criteria include:

  • Areas of Work (Oncology, Clinical Research, Pharmacology, Neuroscience, Molecular Biology, etc.)
  • Geography (USA, Europe, Asia, ME/Africa and RoW)
  • Job Titles
  • Institution Type (Academic / Commercial)

CPC Banner advertisements (First 10 clicks for FREE)

  • Banner advertisement on scholarly article pages of a relevant journal for a month (above 50 impressions per day for each banner)
  • Banner advertising on Table of Content alert to our Editorial Board Members, Subscribers and Contributors
  • Banner advertisement on the home page of a relevant journal for a month.
  • Banner advertisement on the home page of a relevant eBook to your preference.
  • Company logo on Media Partner’s section
  • Banner advertisement under the partnering events section on Bentham Science website (Complimentary with the Package)

Social Media Promotion/Campaign (Twitter, Facebook, LinkedIn, WordPress)

 

In addition, we will provide you a detailed report regarding the performance of the ads, including the stats for the following:

✔Impressions

✔Clicks and CTR

✔Conversions (where possible)

You can also avail Print Advertising and Customized Email Promotion Packages with nominal costs that best suit your requirements. For details about the Packages and costs please contact at hermain@benthamscience.net or faizan@benthamscience.net OR visit: http://bit.ly/2snuJiQ

Press Release for EurekAlert! Non-ambient conditions in the investigation and manufacturing of drug forms

Before it reaches the store shelf, a drug molecule must be prepared in a very specific way. The nature of this prepared form is of the utmost importance, as it must be robust through manufacture, packaging, transport and storage. Ultimately, this prepared drug form must have the necessary physical properties to ensure that the correct amount of drug is available to the consumer. For the successful preparation of this drug form, one often needs to produce solid samples with a controlled crystal structure and specific particle size and shape. To complicate matters, these drug crystals are often required as a part of multi-component composites. The present review summarizes how extreme pressure and temperature conditions help to achieve this goal.

cecea6487bb6533f924c57e4a5dfdfd373bb10e3aaa475caebpimgpsh_fullsize_distr

To become a drug, a pharmacologically active compound must be prepared in a specific form. This form must be robust during manufacturing, packaging, storage and transport, and must administer the correct dose to the patient. To successfully prepare a drug form, one often needs to produce solid samples with controlled crystal structure and a specific particle size and shape. To further complicate matters, these compounds, these drug particles must often end up as a part of a multi-component composite. The present review summarizes how extreme pressure and temperature conditions help achieve this highly tuned material.

In modern culture, it is very rare to find an individual who has never taken any form of medication. It must follow that the pharmaceutical industry is required to produce an enormous quantity of drug products, which can take  a variety of different forms: solutions for injections, inhalation powders, sprays, tablets, ointments, patches, amongst others. In many cases, although adopting different administration routes, different trade names are used to market the very same active pharmaceutical ingredient (API). This begs the question: if these products are the same API, is there any difference in which form is taken?

Quite simply put, yes.

Drug molecules move around the body and, by necessity, act at the molecular level. However, many of these compounds are manufactured as solids, which must either be dissolved prior to injection, or are expected to dissolve on digestion in biological fluids. In either case, dissolution is required to release individual molecules into the body.

Solid pharmaceuticals containing the same API (either pure or with additives) can have different crystal structures (polymorphism) or be amorphous. Additionally, solid particles can differ in size, shape, meso-structure, and surface charge. Within the bulk material, the spatial distribution of an API and the additives can vary. Control of these, and many other, characteristics is within the scope of materials sciences and solid-state chemistry. The chemical and material properties of their physical form therefore needs to be identified and optimized for in vivo performance, reliable manufacture and the protection of intellectual property. 

Drugs are materials, not simply molecules [1-12], By viewing drugs in this way, one can apply the knowledge of solid-state chemistry, materials science and non-ambient conditions to obtain solid forms with optimized properties. These conditions include, among others, different types of mechanical and ultrasonic treatment, hydrostatic compression, high-temperature or cryogenic spray-drying, and crystallization from supercritical solvents. Solid-state reactions (e.g. dehydration or clathrate decomposition) can be efficient in accessing metastable polymorphs or in uniformly micronizing the sample. To achieve control over drug forms and the processes used for their robust manufacturing, one needs to account for both the thermodynamic and kinetic aspects of their transformations.

The review contains over 400 references and provides a comprehensive guide through the vast ocean of publications in this field. This work is based on the personal experience of the author over several decades of active research. ###

For more information visit: http://benthamscience.com/journals/current-pharmaceutical-design/volume/22/issue/32/page/4981/

Elena V Boldyreva

Institute of Solid State Chemistry and Mechanochemistry, Siberian Branch of Russian Academy of Sciences, ul. Kutateladze, 18, Novosibirsk 630128 Russia

 

New Issue :: Pharmaceutical Nanotechnology, 4 Issue 3

Pharmaceutical Nanotechnology publishes original manuscripts, reviews, thematic issues, rapid technical notes and commentaries that provide insights into the synthesis, characterisation and pharmaceutical (or diagnostic) application of materials at the nanoscale. The nanoscale is defined as a size range of below 1 µm. Scientific findings related to micro and macro systems with functionality residing within features defined at the nanoscale are also within the scope of the journal. Manuscripts detailing the synthesis, exhaustive characterisation, biological evaluation, clinical testing and/ or toxicological assessment of nanomaterials are of particular interest to the journal’s readership. Articles should be self contained, centred around a well founded hypothesis and should aim to showcase the pharmaceutical/ diagnostic implications of the nanotechnology approach. Manuscripts should aim, wherever possible, to demonstrate the in vivo impact of any nanotechnological intervention. As reducing a material to the nanoscale is capable of fundamentally altering the material’s properties, the journal’s readership is particularly interested in new characterisation techniques and the advanced properties that originate from this size reduction. Both bottom up and top down approaches to the realisation of nanomaterials lie within the scope of the journal.

p

Articles from the journal Pharmaceutical Nanotechnology, Volume 4 Issue 3:

 

For details on the articles, please visit this link :: http://bit.ly/2dpfBpN

eBooks Catalog – Pharmaceutical Science

Catalog Description:

This catalog of our eBook titles in pharmaceutical sciences comprises various ebooks on advances in cancer drug targets, anti-angiogenesis drug discovery and development, anti-obesity drug discovery and development, biopolymers in drug delivery, polymeric nanomedicines, recent trends on QSAR in the pharmaceutical perceptions, reviews in pharmaceutical and biomedical analysis, opportunities and limitations for biotechnology innovation in Brazil, solubility, delivery and ADME problems of drugs and drug-candidates, the role of new technologies in medical microbiological research and diagnosis, translational animal models in drug discovery and development, treatise on ocular drug delivery, veterinary PCR diagnostics , frontiers in anti-infective drug discovery and many more.

Download here.

Recently Published Issue of The Journal: Current Pharmaceutical Analysis

Current Pharmaceutical Analysis publishes expert reviews and original research articles on all the most recent advances in pharmaceutical and biomedical analysis. All aspects of the field are represented including drug analysis, analytical methodology and instrumentation. The journal is essential to all involved in pharmaceutical, biochemical and clinical analysis.

Following are the articles recently published in the journal Current Pharmaceutical Analysis, 11 Issue 01:

Article: The Site-specific Protonation Constants of Spectinomycin, Characterized by 1H and 15N NMR Methods  

Author(s): Mate Somlyay, Gabor Orgovan and Bela Noszal

Article: Application of Droplet Size Analysis for the Determination of the Required HLB of Lemon Oil in O/W Emulsion

Author(s): N.A. Niczinger, N. Kallai-Szabo, J. Dredan, L. Budai, M. Hajdu and I. Antal

 

Article: Electrochemical Analysis of Cyanuric Acid Using Polyaniline/CuGeO3 Nanowires as Electrode Modified Materials

Author(s): L.Z. Pei, H.D. Liu, N. Lin, Y.K. Xie and Z.Y. Cai

 

Article: Simultaneous Analysis of Losartan Potassium and its Related Impurities and Degradation Products in Tablets Using HPLC

Author(s): Shuhong Qiu, Kai Liu, Panqin Ma, Menglin Wang, Hongming Chen, Xiaochao Xu, Xiaoli Hao and Yongjun Wang

Article: LC-MS/MS Assay for Quantification of a Novel Antitubercular Molecule S006-830: Pharmacokinetic and Plasma Protein Binding Studies in Rats

Author(s): Mahendra Kumar Hidau, Yeshwant Singh, Sudhir Shahi, Poojari Mounika and Shio Kumar Singh

 

Article: Method Development & Validation of LCMS/MS for Atorvastatin and Olmesartan in Human Plasma to Trace Drug Interaction of Formulation          

Author(s): Rakesh Das and T.K. Pal

 

Article: The Effect of Albumin-genotype on Ibuprofen Displacement of Nifedipine from its Binding Sites.

Author(s): Eman Atef and Ahmed S. Mehanna

 

Article: High Sensitivity C-reactive Protein and Cardiovascular Risk Prediction

Author(s): Andreja Trpkovic, Julijana Stanimirovic, Ivana Resanovic, Petar Otasevic, Danimir Jevremovic, Radak Djordje and Esma R. Isenovic

 

Article: Analysis of Tocopherols and Tocotrienols in Pharmaceuticals and Foods: A Critical Review

Author(s): Dan Lu, Yi Yang, Yongxin Li and Chengjun Sun

For details, please visit: http://bit.ly/1BjtM3A

 

Essential Journals on Biotechnology

 

Essential journals on Biotechnology

Click on the journal to access the complete list of articles:
Current Pharmaceutical Biotechnology
Current Bioinformatics
Current Immunology Review

Browse journals by subject here: http://bit.ly/1oNS4Sa

Recent Issue of the BSP Journals have been Published

Current Pharmaceutical Design, 20 Issue 38

Aims & scope

Current Pharmaceutical Design publishes timely in-depth reviews and research articles from leading pharmaceutical researchers in the field, covering all aspects of current research in rational drug design. Each issue is devoted to a single major therapeutic area guest edited by an acknowledged authority in the field.

Each thematic issue of Current Pharmaceutical Design covers all subject areas of major importance to modern drug design including: medicinal chemistry, pharmacology, drug targets and disease mechanism.

http://www.eurekaselect.com/124887/issue/38

Abstracted & Indexed in

Biochemistry & Biophysics Citation Index®, BIOSIS, Chemical Abstracts, Current Contents®/Life Sciences, EMBASE/Excerpta Medica, MEDLINE/Index Medicus, Medical Documentation Service®, Research Alert®, Science Citation Index®, Science Citation Index Expanded (SciSearch®), Cambridge Scientific Abstracts (CSA), PubsHub, Journal Citation Reports/Science Edition, Index to Scientific Reviews®, Custom Information Services®, BIOSIS Previews, BIOSIS Reviews Reports and Meetings, Scopus, Genamics JournalSeek, and J-Gate.

For details about the latest issues, visit:http://benthamscience.com/journal/index.php?journalID=cpd

 

Current Pharmaceutical Design, 20 Issue 39

Aims & scope

Current Pharmaceutical Design publishes timely in-depth reviews and research articles from leading pharmaceutical researchers in the field, covering all aspects of current research in rational drug design. Each issue is devoted to a single major therapeutic area guest edited by an acknowledged authority in the field.

Each thematic issue of Current Pharmaceutical Design covers all subject areas of major importance to modern drug design including: medicinal chemistry, pharmacology, drug targets and disease mechanism.

http://www.eurekaselect.com/124928/issue/39

Abstracted & Indexed in

Biochemistry & Biophysics Citation Index®, BIOSIS, Chemical Abstracts, Current Contents®/Life Sciences, EMBASE/Excerpta Medica, MEDLINE/Index Medicus, Medical Documentation Service®, Research Alert®, Science Citation Index®, Science Citation Index Expanded (SciSearch®), Cambridge Scientific Abstracts (CSA), PubsHub, Journal Citation Reports/Science Edition, Index to Scientific Reviews®, Custom Information Services®, BIOSIS Previews, BIOSIS Reviews Reports and Meetings, Scopus, Genamics JournalSeek, and J-Gate.

For details about the latest issues, visit: http://benthamscience.com/journal/index.php?journalID=cpd

 

Cardiovascular & Hematological Disorders-Drug Targets, 14 Issue 3

Aims & scope

Cardiovascular & Hematological Disorders-Drug Targets aims to cover all the latest and outstanding developments on the medicinal chemistry, pharmacology, molecular biology, genomics and biochemistry of contemporary molecular targets involved in cardiovascular and hematological disorders e.g. disease specific proteins, receptors, enzymes, genes. Each issue of the journal contains a series of timely in-depth, reviews, original research articles, drug clinical trial studies and guest edited thematic issues written by leaders in the field covering a range of current topics on drug targets involved in cardiovascular and hematological disorders. As the discovery, identification, characterization and validation of novel human drug targets for cardiovascular and hematological drug discovery continues to grow; this journal is essential reading for all pharmaceutical scientists involved in drug discovery and development.

http://www.eurekaselect.com/125080/issue/3

Abstracted & Indexed in

MEDLINE/Index Medicus, EMBASE/Excerpta Medica, Scopus, Chemical Abstracts, BIOSIS Reviews Reports and Meetings, BIOSIS Previews, BIOSIS, BIOBASE, CSA, MediaFinder®-Standard Periodical Directory, Genamics JournalSeek, PubsHub, and J-Gate.

For details about the latest issues, visit:http://benthamscience.com/journal/index.php?journalID=chddt

 

Current Drug Targets, 15 Issue 11

Aims & scope

Current Drug Targets aims to cover the latest and most outstanding developments on the medicinal chemistry and pharmacology of molecular drug targets e.g. disease specific proteins, receptors, enzymes, genes.

Current Drug Targets publishes guest edited thematic issues written by leaders in the field covering a range of current topics of drug targets. The journal also accepts for publication mini- & full-length review articles and drug clinical trial studies.

As the discovery, identification, characterization and validation of novel human drug targets for drug discovery continues to grow; this journal is essential reading for all pharmaceutical scientists involved in drug discovery and development.

http://www.eurekaselect.com/125212/issue/11

Abstracted & Indexed in

Chemical Abstracts, BIOSIS Previews, BIOSIS Reviews Reports and Meetings, Science Citation Index Expanded® (Sci Search), Index to Scientific Reviews®, Biochemistry & Biophysics Citation Index®, PUBMED, BIOSIS, Journal Citation Reports/Science Edition, EMBASE/Excerpta Medica, MediaFinder-Standard Periodical Directory, Medline, Scopus, EMBASE, Genamics Journal Seek, PubsHub, and J-Gate.

For details about the latest issues, visit: http://benthamscience.com/journal/index.php?journalID=cdt

 

Current Medical Imaging Reviews, 10 Issue 3

Aims & scope

Current Medical Imaging Reviews publishes frontier review articles, original research articles, drug clinical trial studies and guest edited thematic issues on all the latest advances on medical imaging dedicated to clinical research. All relevant areas are covered by the journal, including advances in the diagnosis, instrumentation and therapeutic applications related to all modern medical imaging techniques.

The journal is essential reading for all clinicians and researchers involved in medical imaging and diagnosis.

http://www.eurekaselect.com/124511/issue/1

Abstracted & Indexed in

Chemical Abstracts, EMBASE, Scopus, EMNursing, Current Contents/Clinical Medicine, Index to Scientific Reviews, Science Citation Index Expanded, JCR/Science Edition, Genamics JournalSeek, MediaFinder®-Standard Periodical Directory, PubsHub, and J-Gate.

For details about the latest issues, visit: http://benthamscience.com/journal/index.php?journalID=cmir

BSP Attended Events

Bentham Science Publishers attends international #events, all year round.
Another upcoming event in the #global #calendar of #BSP is The 134th Annual Meeting of Pharmaceutical Society of Japan.
This #conference will be held at Kumamoto, Japan on the 27th to 30th #March 2014.
For details on the Annual Meeting, please visit: Pharmaceutical Company of Japan
For information on Bentham Science Publishers, please visit: www.benthamscience.com

Bentham-Logo (2)

upcoming_events

%d bloggers like this: